NEW Join or new Affiliate program, earn more shopping more!
Every batch is independently tested by Janoshik for quality and transparency.
High purity and accurate concentration.
High Purity
Accurate
No Harmful Additives
Cagrilintide
- This compound requires bacteriostatic water for reconstitution.
This product is currently sold out.
No worries! Enter your email, and we'll let you know as soon as it's back in stock.
Product Information
Cagrilintide is an investigational, long-acting peptide analogue of amylin, a hormone naturally released by the pancreas alongside insulin after meals. It is being studied for its role in appetite regulation, satiety and body-weight management.
Mechanism of Action
Amylin Pathway Activation
Amylin is a hormone involved in regulating the body’s response to food. It contributes to satiety and influences digestive processes that help coordinate food intake.
Cagrilintide is designed to reproduce and extend aspects of amylin signalling, with a longer duration of action than naturally occurring amylin.
Appetite and Satiety
Cagrilintide is being studied for its ability to influence appetite-related signalling and increase feelings of fullness.
By acting on pathways involved in meal termination and satiety, it may help reduce food intake. The extent of this effect varies between individuals and is being evaluated through controlled clinical trials.
Gastric Emptying
Amylin-related signalling can influence gastric emptying, the process by which food moves from the stomach into the small intestine.
This effect may contribute to satiety and gastrointestinal tolerability. Its magnitude and clinical relevance depend on the treatment and individual response.
Body-Weight Regulation
Clinical research has evaluated cagrilintide as a potential treatment for people living with overweight or obesity.
Results from the phase 3 REDEFINE 1 trial demonstrated a reduction in average body weight compared with placebo after 68 weeks. These findings support further investigation but do not establish that every individual will experience the same result.
Cagrilintide and Semaglutide
Two Complementary Mechanisms
Cagrilintide is also being investigated in combination with semaglutide in an investigational fixed-dose product known as CagriSema.
The combination brings together two distinct pathways:
Cagrilintide
An amylin analogue studied for its effects on satiety and appetite regulation.
Semaglutide
A GLP-1 receptor agonist that influences glucose-dependent insulin secretion, appetite and digestive function.
The scientific rationale is to combine complementary biological mechanisms within one treatment. The combination remains subject to regulatory review and continued clinical evaluation.
Cagrilintide and semaglutide are distinct active compounds. Their investigational combination should not be confused with cagrilintide monotherapy.
Areas of Clinical Research
Weight Management
Cagrilintide is being investigated for chronic weight management in adults with overweight or obesity. Research examines changes in body weight, waist circumference, treatment tolerability and the maintenance of weight reduction over time.
Appetite Regulation
Researchers are studying how sustained amylin-related signalling affects satiety, meal size and overall energy intake.
Combination Therapy
Clinical trials are evaluating cagrilintide alongside GLP-1 and GIP/GLP-1-based treatments to investigate whether complementary pathways can provide additional benefits.
These remain research questions. Outcomes depend on the specific treatment combination, study population and trial design.
FAQ
Before reconstitution, this product is stable at room temperature for short periods, such as during shipping, but refrigeration is recommended for longer-term storage. After reconstitution, it must be refrigerated. Keep away from direct light. This product is stored refrigerated until it ships.
Peptides are made up of chains of amino acids, and some of those amino acids are hydrophobic — meaning they don’t interact well with water. When a peptide contains a high percentage of these hydrophobic residues, it tends to resist dissolving in water and will aggregate, or clump together. These clumps can then trap water, forming a gel-like or stringy texture rather than dissolving into a nice, smooth solution.
Other contributing factors include:
High peptide concentration – Crowding the solution can push molecules together.
pH and temperature – Solubility can vary depending on how acidic or warm the environment is.
Solvent selection – Some peptides do better with alternatives to bacteriostatic water, such as acetic acid or DMSO.
Reconstitution speed – Adding diluent too quickly can shock the peptide into clumping.
Even if the peptide isn’t highly hydrophobic, under the right (or wrong) circumstances, it can still temporarily behave this way.
While nearly any peptide can gel under the right conditions, some are well-known for their gelling tendencies. Here’s a list of the usual suspects:
AOD-9604
Probably the most infamous of all — AOD tends to form a thick, stringy gel if not handled carefully. This one is very hydrophobic and sensitive to temperature and concentration.
GHK-Cu
Copper-bound peptides like GHK-Cu can form gels or crystals depending on the solvent used and the ambient pH. Copper itself doesn’t help the solubility much.
Thymosin Beta-4 (TB-500)
While this one often dissolves well at lower concentrations, it can develop a gel-like consistency if overdosed into a small volume of liquid.
Melanotan II
Known for being finicky, MT2 can clump or gel, especially if it’s cold when reconstituted or the water is added too quickly.
CJC-1295 (DAC and non-DAC)
This longer peptide sometimes forms viscous solutions, especially when not given time to dissolve fully. It benefits from warm temps and slow mixing.
BPC-157
BPC usually dissolves well, but under some conditions (like high concentration or cold storage), it may start to gel or form strands.
IGF-1 LR3
This is more rare, but at high concentrations or if pH is off, this growth factor can aggregate and become cloudy or sticky.
Epitalon
A short peptide, but still known to occasionally form light gels — especially if the reconstitution environment is less than ideal.
Selank / Semax Variants
These nootropic peptides are usually stable but have been reported to gel when compounded at higher concentrations or exposed to rapid temperature changes.
If you’re dealing with a gelling peptide, here are a few simple tips that can help bring it back into proper solution:
1. Warm the vial gently
Let the vial come to room temperature before reconstituting. If needed, place it in a warm (not hot!) water bath for a few minutes to loosen things up.
2. Add your solvent slowly
Instead of blasting bacteriostatic water into the vial, let it drip slowly down the side. This allows the peptide to dissolve gradually and reduces shock to the material.
3. Swirl, don’t shake
Shaking creates bubbles and doesn’t help dissolve aggregates. A gentle swirl or rolling the vial between your hands is more effective.
4. Let it sit
Sometimes the peptide just needs time. Let it rest after adding solvent, then check back in 10–15 minutes and gently swirl again.
5. Try an alternate solvent
If the peptide still doesn’t dissolve, small amounts of 0.6% acetic acid or even DMSO (for research use only) can help break up stubborn hydrophobic clumps.
6. Dilute further if needed
If you’re working with a very high concentration, it may be helpful to use a larger volume of solvent to encourage full dissolution.
Peptide gelling is not a quality issue, nor is it a manufacturing problem — it’s simply a result of biochemical properties interacting with water and environment. Hydrophobic sequences, high concentrations, or quick handling can all lead to temporary clumping or gel formation.
With a little patience and the right technique, almost all gelling issues can be reversed or avoided. If you work with these peptides regularly, getting familiar with their personalities — and knowing how to coax them into solution — will save you time and frustration.
So next time your peptide gels, just remember: it’s not broken — it’s just being dramatic.
